Trial intelligence / Profile preview

ONSD changes in RALRP with Desflurane vs Propofol

NCT03152981Completed

Sponsor
Seoul National University Hospital
Start
Jun 2017
Primary completion
Dec 2017
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised trial of desflurane and propofol injection (veterinary) in prostate cancer (PCa) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Optic Nerve Sheath Diameter. Started Jun 2017; status: completed.

02

Drugs

desfluranepropofol injection (veterinary)
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT03152981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03152981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call